Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 3Herpes Zoster 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Papillomavirus Infections 2Neoplasms 2Melanoma 2Lung Neoplasms 2Influenza, Human 2Glioblastoma 2Whooping Cough 1Waldenstrom Macroglobulinemia 1Tetanus 1Spondylitis, Ankylosing 1Psoriasis 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Glandular and Epithelial 1Multiple Myeloma 1Meningitis 1Medulloblastoma 1Hematologic Neoplasms 1Glioma 1Diphtheria 1Diabetes Mellitus, Insulin-Dependent, 12 1Crohn Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1

Interventions

antineoplaston AS 2-1 3antineoplaston A10 3dactolisib 2Temozolomide 2Irinotecan 2Everolimus 2Bevacizumab 2surufatinib 1spartalizumab 1poly ICLC 1plerixafor 1pasireotide 1fosbretabulin 1cixutumumab 1adavosertib 1Vaccines 1TH 302 1Sunitinib 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiation 1PM 00104 1Lapatinib 1Immunologic Techniques 1Immunoglobulin G 1Genistein 1Fentanyl 1Donepezil 1Disulfides 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neuroectodermal Tumors, Primitive × Vaccines × Clear all
NCT02332889 2018-05-04

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

University of Louisville

Phase 1/2 Terminated
1 enrolled 6 charts
CNS

Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡